Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Nanshan Branch of Qilu Hospital | UNKNOWN |
Not provided
Not provided
Not provided
Not provided
Effectiveness of fasting or fasting-mimicking diet has been proved an effective approach to treat metabolic and autoimmune diseases in mice. However, clinical trials performing prolonged fasting with more than 7 days have not been reported. Investigators conduct an open label, phase I/II clinical trial to evaluate the safety and effectiveness of the 21-day fasting-like diet in the treatment of metabolic and autoimmune diseases.
Although fasting has been proved an effective approach to treat metabolic and autoimmune diseases in mice, prolonged fasting is difficult to implement in human-beings for the safety and feasibility reasons.
In this clinical trial, we will recruit metabolic and autoimmune diseases and then follow a traditional Chinese 21-day fasting-like diet process with extremely low calorie intake (about 5% of normal diet) and prolonged fasting-like period. Blood, urine, stool samples will be collected on day 0 (baseline), day 4, day 7, day 14, day 21 and day 51 after it started up. Therefore we can examine the changes of disease-associated physical indexes and metabolic biomarkers pre and post the 21-day fasting-like diet.
The purpose of the study is to ascertain the impact of the fasting-like diet during the 21 days. The investigators hypothesize that the 21-day fasting-like diet can reduce the biomarkers associated with aging and age-related diseases and benefit for the treatment of metabolic and autoimmune diseases.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| the 21-day fasting-like diet | Participants will be supplied with fasting-like diet containing only 5% of normal calorie intake. Physical examinations will be performed on day 0, 4,7,14,21 and 51 after the clinical trial. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| the 21-day fasting-like diet | Other | a fasting-like diet with 400 KJ energy intake per day for 21 days |
|
| Measure | Description | Time Frame |
|---|---|---|
| Number of participants with treatment-related adverse events as assessed by CTCAE v4.0. | Phase I: To obtain preliminary estimates of the safety of the fasting-like diet. | 30 days after the fasting-like diet |
| Evaluation of the therapeutic effects on metabolic disorder-associated diseases by the examination of metabolic biomarkers. | Phase II: To compare the state of diseases pre and post fasting-like diet by the examination of comprehensive metabolic panel. | 30 days after the fasting-like diet |
| Measure | Description | Time Frame |
|---|---|---|
| Functional changes in the peripheral blood lymphocytes pre and post fasting-like diet as accesse by flow cytometry and RNA-seq. | Peripheral blood samples were collected at indicated time points and analyzed by flow cytometry for the composition of lymphocyte subsets and by RNA-seq for their functions. | Baseline, 4 days, 7 days, 14 days, 21 days, 51 days after the beginning of the fasting-like diet |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Of these 144 participants, 55 were male and 89 were female. For detailed information, please follow our recent publications.
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Ligang Ming, MD | Nanshan Branch of Qilu Hospital | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Nanshan Branch of Qilu Hospital | Longkou | Shandong | 265706 | China |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Compositional changes in intestinal microflora pre and post fasting-like diet as accesse by RNA-seq. | Stool samples were collected in time if possible and analyzed by RNA-seq for the composition of the intestinal microflora. | Baseline, 4 days, 7 days, 14 days, 21 days, 51 days after the beginning of the fasting-like diet |
| ID | Term |
|---|---|
| D005215 | Fasting |
| D002908 | Chronic Disease |
| D001327 | Autoimmune Diseases |
| D008659 | Metabolic Diseases |
| D006973 | Hypertension |
| D005234 | Fatty Liver |
| D007669 | Kidney Calculi |
| D042882 | Gallstones |
| ID | Term |
|---|---|
| D005247 | Feeding Behavior |
| D001519 | Behavior |
| D020969 | Disease Attributes |
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D007154 | Immune System Diseases |
| D009750 | Nutritional and Metabolic Diseases |
| D014652 | Vascular Diseases |
| D002318 | Cardiovascular Diseases |
| D008107 | Liver Diseases |
| D004066 | Digestive System Diseases |
| D053040 | Nephrolithiasis |
| D007674 | Kidney Diseases |
| D014570 | Urologic Diseases |
| D052776 | Female Urogenital Diseases |
| D005261 | Female Urogenital Diseases and Pregnancy Complications |
| D000091642 | Urogenital Diseases |
| D052878 | Urolithiasis |
| D014545 | Urinary Calculi |
| D052801 | Male Urogenital Diseases |
| D002137 | Calculi |
| D020763 | Pathological Conditions, Anatomical |
| D002769 | Cholelithiasis |
| D001660 | Biliary Tract Diseases |
| D041761 | Cholecystolithiasis |
| D005705 | Gallbladder Diseases |
Not provided
Not provided